financetom
Business
financetom
/
Business
/
Colgate-Palmolive raises sales growth target after strong Q1 results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Colgate-Palmolive raises sales growth target after strong Q1 results
Apr 26, 2024 4:51 AM

April 26 (Reuters) - Toothpaste maker Colgate-Palmolive ( CL )

raised forecast for annual organic sales growth on

Friday, banking on resilient demand for its highly priced

self-care and pet nutrition products.

Demand for Colgate-Palmolive's ( CL ) products, including personal

care and pet food, held strong as consumers stretched their

budgets to spend on daily essentials.

Earlier this month, larger peers Procter & Gamble ( PG ) and

Kimberly-Clark ( KMB ) also saw sales rise thanks to strong

consumer demand.

Colgate-Palmolive ( CL ) now expects full-year organic sales growth

in the range of 5% to 7%, compared with its prior forecast of 3%

to 5% growth.

Benefits from price hikes and easing costs of raw and

packaging materials helped the company expand its margins by 310

basis points to 60%.

The Palmolive shower gel maker's prices rose by 8.5% in the

first quarter, while organic sales volumes were up 1.3%,

improving from a 2% dip last year.

The company posted net sales of $5.07 billion for the

quarter ended March 31, compared with analysts' average estimate

of $4.96 billion, according to LSEG data.

On an adjusted basis, it earned 86 cents per share, topping

analysts' estimate of 81 cents per share.

Shares of the household and consumer products firm, which

are up 12% so far this year, rose 3% in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Agios Pharmaceuticals' Q4 Loss Widens, Revenue Rises
Agios Pharmaceuticals' Q4 Loss Widens, Revenue Rises
Feb 13, 2025
07:04 AM EST, 02/13/2025 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) reported a Q4 net loss Thursday of $96.5 million, wider than a loss of $95.9 million a year earlier. Two analysts polled by FactSet expected a loss of $94.2 million. Revenue for the quarter ended Dec. 31 was $10.7 million, up from $7.1 million a year earlier. Analysts...
Brookfield's Q4 Distributable Earnings Rise, Revenue Falls; Quarterly Dividend Raised
Brookfield's Q4 Distributable Earnings Rise, Revenue Falls; Quarterly Dividend Raised
Feb 13, 2025
07:01 AM EST, 02/13/2025 (MT Newswires) -- Brookfield (BN) reported Q4 distributable earnings Thursday of $1.01 per share, up from $0.83 a year earlier. Four analysts polled by FactSet expected $0.85. Revenue for the quarter ended Dec. 31 was $19.43 billion, down from $24.52 billion a year earlier. Analysts' estimates were not readily available for comparison. The company increased its...
What's Going On With D-Wave Quantum Stock Today?
What's Going On With D-Wave Quantum Stock Today?
Feb 13, 2025
D-Wave Quantum Inc. ( QBTS ) revealed that it is enabling research centers, academic institutions, and governments to purchase on-premises D-Wave Advantage quantum computing systems. This move aims to empower organizations to push the boundaries of quantum experimentation and development, with applications focussing quantum simulation. D-Wave’s Advantage system, with over 5,000 qubits and 15-way connectivity, is already available for on-premises...
PBF Energy's Q4 Adjusted Loss Widens, Revenue Falls
PBF Energy's Q4 Adjusted Loss Widens, Revenue Falls
Feb 13, 2025
07:00 AM EST, 02/13/2025 (MT Newswires) -- PBF Energy ( PBF ) reported Thursday its Q4 adjusted loss widened to $2.82 per diluted share, from a loss of $0.41 a year earlier. One analyst polled by FactSet expected a loss of $2.82. Revenue for the quarter ended Dec. 31 was $7.35 billion, down from $9.14 billion a year earlier. One...
Copyright 2023-2026 - www.financetom.com All Rights Reserved